Understanding Your Laboratory Test: What It Is, Why It Is Done, and How to Interpret Your Results
This test detects the presence of Acinetobacter baumannii bacteria DNA in urine using advanced molecular technology.
{"Detects Acinetobacter baumannii bacteria in urine samples","Uses Nucleic Acid Amplification (NAA) technology for high accuracy","Helps diagnose urinary tract infections caused by this bacteria","Results are typically available within 24-48 hours","Important for patients with weakened immune systems or hospital-acquired infections"}
Key facts at a glance
- LOINC
- 99013-5
- Short code
- ACBA-URN
- Synonyms
- A baumannii DNA Ur Ql NAA+probe
- Category
- chemistry
- Sample
- urine
- Container
- Sterile, leak-proof urine container (plastic or glass)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 0 years
- Method
- probe-amp-tar
- CPT
- 87641
- SNOMED
- 448771005
- Specimen volume
- 10-20 mL preferred, minimum 2 mL
- Stability
- Room temperature: 2 hours; Refrigerated (2-8°C): 24-48 hours; Frozen (-20°C or below): 7 days. Transport to laboratory promptly.
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 24–72 hours
- Order
- routine
This test is a laboratory analysis performed on a sample of your blood, urine, or other body tissue to help your doctor evaluate how well your body is functioning and to check for possible signs of illness, infection, or disease.
The Acinetobacter baumannii DNA test is a molecular diagnostic test that detects the genetic material (DNA) of Acinetobacter baumannii bacteria in a urine sample. This test uses Nucleic Acid Amplification (NAA) technology with probe detection, which is highly sensitive and specific in identifying this particular bacterium.
Your doctor may order this test to help diagnose a medical condition, monitor an ongoing health problem, screen for disease before symptoms appear, or track how well your current treatment plan is working over time.
This test is performed when a healthcare provider suspects a urinary tract infection (UTI) caused by Acinetobacter baumannii. It is particularly important for hospitalized patients, those with weakened immune systems, or individuals who have recently undergone urinary catheterization. Acinetobacter baumannii is known for causing healthcare-associated infections and can be resistant to many antibiotics, making accurate detection crucial for proper treatment.
The test is usually done in a clinic, hospital, or laboratory. A trained professional will draw a small blood sample from a vein in your arm, or you may be asked to provide a urine or other sample, which is then sent for analysis.
A urine sample is collected from the patient, typically using a clean-catch midstream urine collection method. The sample is then sent to a laboratory where technicians use NAA technology to detect the presence of Acinetobacter baumannii DNA. This method is more sensitive than traditional culture methods and can provide faster results.
Your results show whether your values fall within the normal reference range for this test. Normal results generally suggest no evidence of disease, while abnormal results may point to a condition that needs further evaluation, follow-up testing, or treatment by your doctor.
A positive result indicates that Acinetobacter baumannii bacteria DNA was detected in the urine, suggesting an active infection. A negative result means no DNA from this bacterium was detected. However, a negative result does not rule out other causes of urinary symptoms, and your healthcare provider will interpret the results in conjunction with your clinical symptoms and other test findings.
Reference range
Not detected - No Acinetobacter baumannii DNA detected in urine specimenN/A
Collect urine specimen using clean-catch midstream technique or from indwelling catheter using aseptic method. Female patients should cleanse periurethral area from front to back. Male patients should cleanse glans penis. Do not collect first morning specimen if possible as it may have been in bladder too long. Maintain proper hydration before collection.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Acinetobacter baumannii is a significant pathogen in healthcare settings, particularly in intensive care units. It can cause urinary tract infections, pneumonia, bloodstream infections, and wound infections. This bacterium is notorious for its ability to develop antibiotic resistance, including multidrug resistance. Early and accurate detection through NAA testing is crucial for guiding appropriate antibiotic therapy and implementing infection control measures to prevent spread in healthcare facilities.
This test is especially valuable in patients with recurrent UTIs, those who have not responded to standard antibiotic treatments, or individuals with underlying conditions such as diabetes, kidney disease, or compromised immune systems. The rapid detection provided by NAA allows for timely intervention and better patient outcomes.
Frequently asked questions
Is this test painful?
How long does it take to get results?
Do I need to prepare for this test?
What happens if the test is positive?
Can this infection be prevented?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy